Publications by authors named "Richard D Hartman"

Claim this Profile
T
Therapeutic Effect of Evenamide, a Glutamate Inhibitor, in Patients With Treatment-Resistant Schizophrenia (TRS): Final, 1-Year Results From a Phase 2, Open-Label, Rater-Blinded, Randomized, International Clinical Trial.
Ravi Anand, Alessio Turolla, Giovanni Chinellato, Arjun Roy, Richard D Hartman

Int J Neuropsychopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Results Indicate Evenamide, A Selective Modulator of Glutamate Release, Is Associated With Clinically Important Long-Term Efficacy When Added to an Antipsychotic in Patients With Treatment-Resistant Schizophrenia.
Ravi Anand, Alessio Turolla, Giovanni Chinellato, Arjun Roy, Richard D Hartman

Int J Neuropsychopharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study of the Pharmacokinetic Properties and the In Vivo Kinetics of Erythrocytes Loaded With Dexamethasone Sodium Phosphate in Healthy Volunteers.
Shodeinde A Coker, Zbigniew M Szczepiorkowski, Alan H Siegel, Antonio Ferrari, Giovanni Mambrini, Richard D Hartman

Transfus Med Rev· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care.
Christopher A Tokin, Frederick O Cope, Wendy L Metz, Michael S Blue, Beth M Potter, Richard D Hartman

Clin Exp Metastasis· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Centrally acting antiemetics mitigate nausea and vomiting in patients with Alzheimer's disease who receive rivastigmine.
Stanford S Jhee, Thomas Shiovitz, Richard D Hartman, John Messina, Ravi Anand

Clin Neuropharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits?
P Murali Doraiswamy, K Ranga Rama Krishnan, Ravi Anand, Hyesung Sohn, Jacquiline Danyluk, Richard D Hartman

Prog Neuropsychopharmacol Biol Psychiatry· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis